These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6334317)

  • 1. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of quipazine and fluoxetine on analgesic-induced catalepsy and antinociception in the rat.
    Malec D; Langwinski R
    J Pharm Pharmacol; 1980 Jan; 32(1):71-3. PubMed ID: 6102137
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine blocks disruptive and discriminative stimulus effects of quipazine.
    Friedman RL; Sanders-Bush E; Barrett RL
    Eur J Pharmacol; 1984 Oct; 106(1):191-3. PubMed ID: 6529966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preweaning cocaine administration alters the adult response to quipazine: comparison with fluoxetine.
    Dow-Edwards DL
    Neurotoxicol Teratol; 1998; 20(2):133-42. PubMed ID: 9536459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of quipazine on behavior under a multiple schedule of reinforcement.
    Poling A; Appel JB
    Pharmacol Biochem Behav; 1978 Apr; 8(4):491-2. PubMed ID: 674254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of haloperidol on the multitrial partial reinforcement extinction effect (PREE): evidence for neuroleptic drug action on nonreinforcement but not on reinforcement.
    Feldon J; Weiner I
    Psychopharmacology (Berl); 1991; 105(3):407-14. PubMed ID: 1686816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of anorexia and motor disruption by cyclazocine and quipazine.
    Henck JW; Rezabek DH; Rech RH
    Pharmacol Biochem Behav; 1985 May; 22(5):671-6. PubMed ID: 4011631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine.
    Haraguchi M; Samson HH; Tolliver GA
    Pharmacol Biochem Behav; 1990 Jan; 35(1):259-62. PubMed ID: 2138332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; El Halawani ME
    Gen Comp Endocrinol; 1983 Dec; 52(3):400-8. PubMed ID: 6230284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extinction and reacquisition of differential responding in rats trained to discriminate between chlordiazepoxide and saline.
    Rijnders HJ; Järbe TU; Slangen JL
    Psychopharmacology (Berl); 1990; 102(3):404-10. PubMed ID: 2251337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
    Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of environmental enrichment on extinction and reinstatement of amphetamine self-administration and sucrose-maintained responding.
    Stairs DJ; Klein ED; Bardo MT
    Behav Pharmacol; 2006 Nov; 17(7):597-604. PubMed ID: 17021392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of quipazine and of tryptamine on self-stimulation of median raphé nucleus and of lateral hypothalamus in rats.
    Broadbent J; Greenshaw AJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):943-7. PubMed ID: 4080780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
    Mokler DJ; Commissaris RL; Henck JW; Rech RH
    Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C; Biala G; Le Bihan C; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2003 Feb; 166(1):19-32. PubMed ID: 12525958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.